Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Greenwich LifeSciences, Inc. GLSI

Full chart Compare
Set alert

Price alert · GLSI

All alert types
16.35 USD 0.00 (+0.00%)

At closeNov 5, 2026, 5:42 AM EST

16.35 0.00 0.00%

Pre-market · Nov 5, 5:42 AM ET

15.76 Day range 16.94
7.78 52-week range 34.10
YTD
-22.18%
1 year
+95.34%

Financial health

Altman Z-Score

2.10 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -14.7×
FY 2017: -38.5×FY 2018: -35.7×FY 2019: -17.2×FY 2020: -243×FY 2021: -69.5×FY 2022: -24.9×FY 2023: -15.2×FY 2024: -9.3×FY 2025: -14.7×
FY 2017 5y median -15.2× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 805×
FY 2017: -6.9×FY 2018: -5.9×FY 2019: -43.5×FY 2020: 16.8×FY 2021: 11.7×FY 2022: 14.9×FY 2023: 20.2×FY 2024: 161×FY 2025: 805×
FY 2017 5y median 20.2× FY 2025
P/FCF -28.7×
FY 2017: -486×FY 2018: -521×FY 2019: -200×FY 2020: -402×FY 2021: -73.4×FY 2022: -31.7×FY 2023: -20.9×FY 2024: -20.1×FY 2025: -28.7×
FY 2017 5y median -28.7× FY 2025
EV/EBITDA -14.4×
FY 2017: -37.4×FY 2018: -35.4×FY 2019: -17.3×FY 2020: -234×FY 2021: -63.0×FY 2022: -23.4×FY 2023: -14.4×FY 2024: -8.2×FY 2025: -14.4×
FY 2017 5y median -14.4× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -3.5%
FY 2017: -0.2%FY 2018: -0.2%FY 2019: -0.5%FY 2020: -0.2%FY 2021: -1.4%FY 2022: -3.2%FY 2023: -4.8%FY 2024: -5.0%FY 2025: -3.5%
FY 2017 5y median -3.5% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -5480.5%
FY 2017: 18.4%FY 2018: 16.7%FY 2019: 253.6%FY 2020: -6.7%FY 2021: -17.0%FY 2022: -59.2%FY 2023: -132.7%FY 2024: -1916.5%FY 2025: -5480.5%
FY 2017 5y median -132.7% FY 2025
ROIC -5505.9%
FY 2017: 296.7%FY 2018: 272.5%FY 2019: 478.9%FY 2020: -6.7%FY 2021: -17.1%FY 2022: -60.8%FY 2023: -139.2%FY 2024: -1941.1%FY 2025: -5505.9%
FY 2017 5y median -139.2% FY 2025
ROA -313.3%
FY 2017: -5805.3%FY 2018: -1556.6%FY 2019: -12842.8%FY 2020: -6.5%FY 2021: -16.8%FY 2022: -58.1%FY 2023: -127.1%FY 2024: -425.4%FY 2025: -313.3%
FY 2017 5y median -127.1% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income -10.3%
FY 2017: 0.0%FY 2018: -7.4%FY 2019: -102.7%FY 2020: 45.6%FY 2021: -146.7%FY 2022: -74.9%FY 2023: -16.0%FY 2024: -89.1%FY 2025: -10.3%
FY 2017 FY 2025
EPS (diluted) -18.2%
FY 2017: 0.0%FY 2018: -7.7%FY 2019: -107.1%FY 2020: 48.3%FY 2021: -133.3%FY 2022: -74.3%FY 2023: -13.1%FY 2024: -75.4%FY 2025: -18.2%
FY 2017 FY 2025
Free Cash Flow -36.4%
FY 2017: 0.0%FY 2018: 4.9%FY 2019: -155.1%FY 2020: -293.1%FY 2021: -272.2%FY 2022: -44.5%FY 2023: -4.5%FY 2024: -12.2%FY 2025: -36.4%
FY 2017 FY 2025

Financial Health

Current Ratio 1.1×
FY 2017: 0.0×FY 2018: 0.1×FY 2019: 0.0×FY 2020: 27.4×FY 2021: 70.6×FY 2022: 51.2×FY 2023: 23.7×FY 2024: 1.3×FY 2025: 1.1×
FY 2017 5y median 23.7× FY 2025
Quick Ratio 1.1×
FY 2017: 0.0×FY 2018: 0.1×FY 2019: 0.0×FY 2020: 27.4×FY 2021: 70.6×FY 2022: 51.2×FY 2023: 23.7×FY 2024: 1.3×FY 2025: 1.1×
FY 2017 5y median 23.7× FY 2025
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: -0.5×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2017: 0.0×FY 2018: 0.1×FY 2019: -0.2×FY 2020: 15.3×FY 2021: 6.0×FY 2022: 1.7×FY 2023: 0.8×FY 2024: 0.2×FY 2025: 0.3×
FY 2017 5y median 0.8× FY 2025
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31